
The miR-200 family controls -tubulin III expression and is associated with paclitaxel-based treatment response and progression-free survival in ovarian cancer patients
Leskela, S., Leandro-Garcia, L. J., Mendiola, M., Barriuso, J., Inglada-Perez, L., Munoz, I., Martinez-Delgado, B., Redondo, A., de Santiago, J., Robledo, M., Hardisson, D., Rodriguez-Antona, C.Volume:
18
Langue:
english
Journal:
Endocrine Related Cancer
DOI:
10.1677/erc-10-0148
Date:
December, 2010
Fichier:
PDF, 285 KB
english, 2010